RxDoctor Payments Data

Michael Piggott, DO

Family Medicine · Marquette, MINPI 1740843861

Payments from drug & device makers

$178in general payments, 2019–2025

Across 10 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$47
  • Boehringer Ingelheim$33
  • Insulet Corporation$22
  • E.r. Squibb & Sons, L.L.C.$18
  • Amgen$17
  • Ultragenyx Pharmaceutical Inc.$15
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$178100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$178 in reported general payments places this provider in the 40th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$44,418
Medicare patients
227
Services billed
468

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban125$135,217
JardianceEmpagliflozin79$88,931
OzempicSemaglutide19$37,756
XareltoRivaroxaban28$37,132
EntrestoSacubitril/Valsartan27$26,165
Spiriva RespimatTiotropium Bromide26$13,207
Novolog FlexpenInsulin Aspart37$9,548
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$6,519
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$6,226
Breo ElliptaFluticasone/Vilanterol13$5,095
Atorvastatin Calcium322$3,891
Humalog Kwikpen U-100Insulin Lispro14$2,354
Metoprolol Succinate122$2,039
Losartan Potassium146$1,824
Omeprazole119$1,542

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat$33$102,138105 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Marquette

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →